Venture-backed Mirum Pharmaceuticals named Chris Peetz as chief executive officer, stepping in for former CEO Mike Grey, who will be in the role of executive chairman of the board. Mirum is backed by investors including NEA, Deerfield Management, Frazier Healthcare Partners, Novo Holdings, Pappas Capital, RiverVest Venture Partners and Rock Springs Capital.
Keensight Capital hires former Meta data science executive as head of AI
8 hours ago · 2 mins read
Falfurrias hires Great Hill’s Greg Stewart to help lead tech, services deals
3 November 2026 · 1 min read
EIV’s Kristin Kelly: From aspiring vet to energy investor
3 November 2026 · 5 mins read
Permira hires former S&P Global CEO Douglas Peterson as senior adviser
2 November 2026 · 2 mins read
o15 Capital Partners hires Capital One’s Rochelle Probst as managing director
29 October 2026 · 1 min read
HighPost Capital hires Quail Ridge founder Ron Sylvestri as managing director, marketing
28 October 2026 · 1 min read
Broad Sky Partners hires ex-Partners Group investor Henry Elefter as managing director
28 October 2026 · 2 mins read
